Cargando…
Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
Multiple sclerosis has been established as an inflammatory disease of the central nervous system. Many aspects of the pathophysiology are still unknown and it is presently unclear how different treatments affect the immunopathology of multiple sclerosis. In this study, we explored cytokines discrimi...
Autores principales: | Burman, Joachim, Zjukovskaja, Christina, Svenningsson, Anders, Freyhult, Eva, Wiberg, Anna, Kultima, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901571/ https://www.ncbi.nlm.nih.gov/pubmed/36756308 http://dx.doi.org/10.1093/braincomms/fcad011 |
Ejemplares similares
-
Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
por: Carlsson, Henrik, et al.
Publicado: (2021) -
CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
por: Lundblad, Katarina, et al.
Publicado: (2023) -
Disease phenotype prediction in multiple sclerosis
por: Herman, Stephanie, et al.
Publicado: (2023) -
Distribution of five clinically important neuroglial proteins in the human brain
por: Sjölin, Karl, et al.
Publicado: (2022) -
Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension
por: Bergman, Joakim, et al.
Publicado: (2020)